Compare TOI & NUTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TOI | NUTX |
|---|---|---|
| Founded | 2007 | 2011 |
| Country | United States | United States |
| Employees | 641 | 944 |
| Industry | Medical/Nursing Services | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 304.4M | 655.4M |
| IPO Year | N/A | 2009 |
| Metric | TOI | NUTX |
|---|---|---|
| Price | $3.40 | $105.20 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | $6.67 | ★ $252.50 |
| AVG Volume (30 Days) | ★ 1.5M | 152.9K |
| Earning Date | 05-13-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 7.93 |
| EPS | N/A | ★ 10.48 |
| Revenue | N/A | ★ $875,257,000.00 |
| Revenue This Year | $30.15 | $6.12 |
| Revenue Next Year | $25.77 | $4.04 |
| P/E Ratio | ★ N/A | $10.05 |
| Revenue Growth | N/A | ★ 82.36 |
| 52 Week Low | $2.02 | $77.21 |
| 52 Week High | $4.88 | $193.07 |
| Indicator | TOI | NUTX |
|---|---|---|
| Relative Strength Index (RSI) | 57.96 | 52.23 |
| Support Level | $3.35 | $94.38 |
| Resistance Level | $3.74 | $111.95 |
| Average True Range (ATR) | 0.21 | 6.19 |
| MACD | 0.02 | 0.89 |
| Stochastic Oscillator | 61.92 | 62.64 |
The Oncology Institute Inc offers oncology care and treatment services to patients through several clinics located across the United States. It offers services such as infusion chemotherapy, oral drug chemotherapy, hospice and palliative care, autologous stem cell transplants, outpatient blood product transfusions, patient navigator programs, radiation oncology, and others on a fee or value-based model. Additionally, the company enrolls patients in clinical trials, where appropriate. The company has three operating segments: Specialty Pharmacy, Patient Services, and Clinical Trials and Other. Maximum revenue is generated from the Specialty Pharmacy segment, which operates specialty and retail pharmacies providing IV-infused, oral, injectable, and other medications for oncology treatment.
Nutex Health Inc is a physician-led, healthcare services and operations company with various hospital facilities in the U.S. states (hospital division), and a primary care-centric, risk-bearing population health management division. The company has three segments: the hospital division, the PHM division, and the real estate division. The hospital division implements and operates health care models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management (PHM) division owns and operates provider networks such as independent physician associations (IPAs). The Real Estate Entities own the land and hospital buildings which are leased to its hospital entities. The majority of the revenue is derived from the Hospital division.